Free Trial

Sensei Biotherapeutics (SNSE) Short Interest Ratio & Short Volume

Sensei Biotherapeutics logo
$0.32 +0.01 (+3.12%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$0.31 -0.01 (-3.50%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensei Biotherapeutics Short Interest Data

Sensei Biotherapeutics (SNSE) has a short interest of 398,100 shares, representing 2.41% of the float (the number of shares available for trading by the public). This marks a -23.98% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 902,794 shares to cover all short positions.

Current Short Interest
398,100 shares
Previous Short Interest
523,700 shares
Change Vs. Previous Month
-23.98%
Dollar Volume Sold Short
$160,434.30
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
25,208,000 shares
Float Size
16,520,000 shares
Short Percent of Float
2.41%
Today's Trading Volume
72,986 shares
Average Trading Volume
902,794 shares
Today's Volume Vs. Average
8%
Short Selling Sensei Biotherapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sensei Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SNSE Short Interest Over Time

SNSE Days to Cover Over Time

SNSE Percentage of Float Shorted Over Time

Sensei Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025398,100 shares $160,434.30 -24.0%2.4%0.2 $0.40
4/15/2025523,700 shares $239,854.60 -72.6%3.2%0.2 $0.46
3/31/20251,910,000 shares $752,540.00 +1,478.5%11.6%0.7 $0.39
3/15/2025121,000 shares $54,571.00 -17.5%0.7%0.4 $0.45
2/28/2025146,700 shares $68,362.20 -14.1%0.9%0.4 $0.47
2/15/2025170,700 shares $81,253.20 -36.0%1.0%0.4 $0.48
1/31/2025266,500 shares $125,255.00 -64.8%1.6%0.6 $0.47
1/15/2025757,800 shares $384,886.62 +594.0%4.6%1.5 $0.51
12/31/2024109,200 shares $53,518.92 +30.5%0.7%0.2 $0.49
12/15/202483,700 shares $36,828.00 -63.1%0.5%0.2 $0.44
11/30/2024226,700 shares $122,644.70 +13.2%1.4%0.5 $0.54
11/15/2024200,300 shares $90,836.05 +2.9%1.2%0.5 $0.45
10/31/2024194,700 shares $92,443.56 -12.8%1.2%0.6 $0.47
10/15/2024223,200 shares $103,788.00 -12.4%1.4%0.9 $0.47
9/30/2024254,800 shares $152,370.40 +1.7%1.5%4.9 $0.60
9/15/2024250,600 shares $135,324.00 -5.2%1.5%5.4 $0.54
8/31/2024264,400 shares $160,173.52 -0.2%1.6%7.3 $0.61
8/15/2024265,000 shares $161,385.00 -0.9%1.6%2.6 $0.61
7/31/2024267,500 shares $181,365.00 -2.3%1.6%2 $0.68
7/15/2024273,900 shares $196,523.25 -2.4%1.7%1.2 $0.72
6/30/2024280,600 shares $174,000.06 -3.2%1.7%1.2 $0.62
6/15/2024289,900 shares $185,043.17 +2.6%1.8%1.2 $0.64
5/31/2024282,600 shares $209,010.96 +250.6%1.7%1.1 $0.74
5/15/202480,600 shares $120,094.00 +34.1%0.5%0.4 $1.49
4/30/202460,100 shares $60,701.00 -25.8%0.4%0.4 $1.01
4/15/202481,000 shares $81,405.00 -48.1%0.5%1.2 $1.01
3/31/2024156,200 shares $164,010.00 +7.1%1.0%2.5 $1.05
3/15/2024145,900 shares $147,359.00 +4.1%0.9%2.4 $1.01
2/29/2024140,100 shares $119,085.00 -2.1%0.9%2.5 $0.85
2/15/2024143,100 shares $112,347.81 -11.4%0.9%2.8 $0.79
1/31/2024161,500 shares $132,430.00 -6.5%1.0%2.7 $0.82
1/15/2024172,700 shares $132,979.00 -14.1%1.1%2.4 $0.77
12/31/2023201,000 shares $139,092.00 +2.3%1.2%2.9 $0.69
12/15/2023196,500 shares $129,690.00 +31.4%1.2%3.1 $0.66
11/30/2023149,600 shares $107,712.00 -11.4%0.9%2.8 $0.72
11/15/2023168,800 shares $102,090.24 +25.6%1.0%3.6 $0.60
10/31/2023134,400 shares $95,558.40 -1.9%0.8%3.1 $0.71
10/15/2023137,000 shares $101,380.00 -0.2%0.8%6.9 $0.74
9/30/2023137,200 shares $109,760.00 -14.4%0.8%7.7 $0.80
9/15/2023160,300 shares $132,103.23 +10.4%0.9%7.8 $0.82
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
8/31/2023145,200 shares $145,200.00 -5.8%0.8%6.9 $1.00
8/15/2023154,100 shares $166,428.00 +3.6%0.9%7.1 $1.08
7/31/2023148,800 shares $187,488.00 -2.2%0.8%6.6 $1.26
7/15/2023152,200 shares $196,338.00 -8.7%0.9%2.2 $1.29
6/30/2023166,700 shares $190,038.00 +11.9%0.9%2.3 $1.14
6/15/2023149,000 shares $199,660.00 -0.9%0.8%2 $1.34
5/31/2023150,300 shares $219,438.00 -2.9%0.7%2 $1.46
5/15/2023154,800 shares $224,460.00 -15.5%1.0%2 $1.45
4/30/2023183,100 shares $272,819.00 +72.4%1.1%2.3 $1.49
4/15/2023106,200 shares $159,300.00 -3.5%0.7%1.3 $1.50
3/31/2023110,000 shares $165,000.00 -1.9%0.7%3.3 $1.50
3/15/2023112,100 shares $155,819.00 +46.9%0.7%2.9 $1.39
2/28/202376,300 shares $119,791.00 -3.3%0.5%1.7 $1.57
2/15/202378,900 shares $112,827.00 +24.6%0.5%1.7 $1.43
1/31/202363,300 shares $87,987.00 +0.6%0.4%1.2 $1.39
1/15/202362,900 shares $98,753.00 -23.2%0.4%1.2 $1.57
12/30/202281,900 shares $122,031.00 -30.2%0.5%1.5 $1.49
12/15/2022117,300 shares $181,815.00 -43.8%0.7%2.2 $1.55
11/30/2022208,800 shares $296,496.00 +14.9%1.2%4.4 $1.42
11/15/2022181,700 shares $258,014.00 -4.5%1.1%3.9 $1.42
10/31/2022190,200 shares $275,790.00 -12.1%1.1%4.7 $1.45
10/15/2022216,300 shares $328,776.00 +15.3%1.3%5.9 $1.52
9/30/2022187,600 shares $290,780.00 -1.8%1.1%5 $1.55
9/15/2022191,000 shares $383,910.00 -0.8%1.1%2.8 $2.01
8/31/2022192,600 shares $367,866.00 -5.7%1.1%2.3 $1.91
8/15/2022204,200 shares $453,324.00 -1.9%1.3%1.9 $2.22
7/31/2022208,200 shares $397,662.00 -4.7%1.3%1.7 $1.91
7/15/2022218,500 shares $450,110.00 -11.2%1.4%1.7 $2.06
6/30/2022246,100 shares $558,647.00 -68.6%1.6%1.8 $2.27
6/15/2022783,300 shares $1.50 million +10.5%5.0%5.6 $1.91
5/31/2022708,800 shares $1.35 million -3.1%4.5%6.9 $1.90
5/15/2022731,700 shares $1.09 million +11.1%4.7%8.6 $1.49
4/30/2022658,600 shares $1.02 million +17.9%4.2%8.9 $1.55
4/15/2022558,700 shares $1.07 million -0.6%3.6%7.8 $1.92
3/31/2022562,100 shares $1.30 million +20.2%3.6%7.8 $2.31
3/15/2022467,800 shares $1.14 million +7.4%3.0%5.6 $2.43
2/28/2022435,700 shares $1.57 million +6.7%2.8%4.9 $3.61
2/15/2022408,500 shares $1.76 million +10.6%2.5%4.6 $4.30
1/31/2022369,300 shares $1.78 million +15.1%2.3%4.2 $4.82
1/15/2022320,900 shares $1.68 million -4.1%1.9%3.8 $5.24
12/31/2021334,700 shares $1.94 million +2.3%N/A0 $5.80
12/15/2021327,300 shares $1.70 million -6.1%2.0%3.9 $5.20
11/30/2021348,400 shares $2.40 million -8.3%2.1%3.4 $6.88
11/15/2021380,100 shares $3.75 million -14.8%2.3%3.4 $9.87
10/29/2021446,000 shares $3.88 million -1.4%2.7%3.5 $8.69
10/15/2021452,400 shares $3.45 million -14.0%2.7%3.6 $7.63
9/30/2021525,900 shares $5.53 million +121.1%3.1%4.3 $10.52
9/15/2021237,900 shares $2.55 million -15.8%1.4%1.8 $10.70
8/31/2021282,500 shares $3.05 million -14.7%1.7%2.7 $10.78
8/13/2021331,200 shares $2.63 million No Change2.0%3.6 $7.95
July 2025 Rule Change to Impact Retirement Investors (Ad)

There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.

Yes, Send Me My FREE Retirement Guide

SNSE Short Interest - Frequently Asked Questions

What is Sensei Biotherapeutics' current short interest?

Short interest is the volume of Sensei Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 398,100 shares of SNSE short. 2.41% of Sensei Biotherapeutics' shares are currently sold short. Learn More on Sensei Biotherapeutics' current short interest.

What is a good short interest percentage for Sensei Biotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.41% of Sensei Biotherapeutics' floating shares are currently sold short.

Is Sensei Biotherapeutics' short interest increasing or decreasing?

Sensei Biotherapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 398,100 shares, a decline of 24.0% from the previous total of 523,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sensei Biotherapeutics' float size?

Sensei Biotherapeutics currently has issued a total of 25,208,000 shares. Some of Sensei Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sensei Biotherapeutics currently has a public float of 16,520,000 shares.

How does Sensei Biotherapeutics' short interest compare to its competitors?

2.41% of Sensei Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sensei Biotherapeutics: Reviva Pharmaceuticals Holdings, Inc. (7.21%), Celularity Inc. (12.21%), Iterum Therapeutics plc (2.75%), Tenaya Therapeutics, Inc. (6.51%), NRx Pharmaceuticals, Inc. (8.47%), Rani Therapeutics Holdings, Inc. (10.31%), Aligos Therapeutics, Inc. (20.79%), Spero Therapeutics, Inc. (1.15%), LAVA Therapeutics (0.81%), Akari Therapeutics, Plc (0.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Sensei Biotherapeutics stock?

Short selling SNSE is an investing strategy that aims to generate trading profit from Sensei Biotherapeutics as its price is falling. SNSE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sensei Biotherapeutics?

A short squeeze for Sensei Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNSE, which in turn drives the price of the stock up even further.

How often is Sensei Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNSE, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:SNSE) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners